Symptomatic hyperlactataemia precipitated by the addition of tetracycline to combination antiretroviral therapy

Lancet Infectious Diseases

Volumn 6, Issue 4, 2006, Pages 249-252

  Blazes, David L ^a,b   Decker, Catherine F ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b Unit 3800   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BIGUANIDE; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LINEZOLID; METFORMIN; RIBAVIRIN; RITONAVIR; TENOFOVIR; TETRACYCLINE; ZIDOVUDINE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; FOLLICULITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLACTATEMIA; LACTIC ACIDOSIS; LIPOATROPHY; MALE; PRIORITY JOURNAL;

EID: 33645101785     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(06)70440-6     Document Type: Review

References (33)

1. Ogedegbe AO, DL Thomas, Diehl AM Hyperlactatemia syndromes associated with HIV therapy Lancet Infect Dis 3 2003 329 337
2. Marceau G, V Sapin, C Jacomet Frequency, risk factors, and outcome of hyperlactatemia in HIV-positive persons: implications for the management of treated patients Clin Chem 49 2003 1154 1162
3. Korhonen T, J Idanpaan-Heikkila, Aro A Biguanide induced lactic acidosis in Finland Europ J Clin Pharmacol 15 1979 407 410
4. Tashima CK Phenformin, tetracycline, and lactic acidosis Br Med J 4 1971 557 558
5. Montoliu J, M Carrera, A Darnell, Revert L Lactic acidosis and Fanconi's syndrome due to degraded tetracycline. Br Med J Clin Res Ed 283 1981 1576 1577
6. Apodaca AA, Rakita RM Linezolid induced lactic acidosis N Engl J Med 348 2003 86 87
7. Moyle GJ, D Datta, S Mandalia Hyperlactatemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors AIDS 16 2002 1341 1349
8. Worth L, J Elliott, J Anderson A cautionary tale: fatal lactic acidosis complicating nucleoside analogue and metformin therapy Clin Infect Dis 37 2003 315 316
9. Wohl DA, CD Pilcher, S Evans Absence of sustained hyperlactatemia in HIV infected patients with risk factors for mitochondrial toxicity J Acquir Immune Defic Syndr 35 2004 274 278
10. Butt AA Safety and efficacy of switching to alternative nucleoside analogues following symptomatic hyperlactatemia and lactic acidosis AIDS 17 2003 2495 2499
11. Gerard Y, L Maulin, Y Yazdanpanah Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy AIDS 14 2000 2723 2730
12. Cote HC, ZL Brumme, KJ Craib Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV infected patients N Engl J Med 346 2002 811 820
13. Arenas-Pinto A, AD Grant, S Edwards, Weller IV Lactic acidosis in HIV infected patients: a systematic review of published cases Sex Transm Infect 79 2003 340 344
14. Imhof A, B Ledergerber, Gunthard HF, S Haupts, Weber R Risk factors for and outcome of hyperlactatemia in HIV infected persons: is there a need for routine lactate monitoring? Clin Infect Dis 41 2005 721 728
15. Masia M, F Gutierrez, S Padilla, JM Ramos, Pasqual J Severe toxicity associated with the combination of tenofovir and didanosine: case report and review Int J STD AIDS 16 2005 646 648
16. Murphy MD, M O'Hearn, Chou S Fatal lactic acidosis and acute renal failure after addition of tenofovir to an antiretroviral regimen containing didanosine Clin Infect Dis 36 2003 1082 1085
17. Freneaux E, G Labbe, P Letteron Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: possible role in microvesicular steatosis induced by this antibiotic Hepatology 8 1988 1056 1062
18. Amacher DE, Martin BA Tetracycline-induced steatosis in primary canine hepatocyte cultures Fundam Appl Toxicol 40 1997 256 263
19. Spooner PR Oxytetracycline inhibition of mitochondrial protein synthesis in bovine lymphocytes infected with Theileria parva or stimulated by mitogen Parasitology 101 1990 387 393
20. Van den Bogert C, M Lont, M Mojet, Kroon AM Impairment of liver regeneration during inhibition of mitochondrial protein synthesis by oxytetracycline Biochim Biophys Acta 722 1983 393 400
21. Goli AK, SA Goli, Byrd RP Jr, Roy TM Simvastatin-induced lactic acidosis: a rare adverse reaction? Clin Pharmacol Ther 72 2002 461 464
22. Neale R, TM Reynolds, Saweirs W Statin precipitated lactic acidosis? J Clin Pathol 57 2004 989 990
23. Loscher W, H Nau, U Wahnschaffe Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. II. Influence of phenobarbital comedication Epilepsy Res 15 1993 113 131
24. Fromenty B, C Fisch, G Labbe Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice J Pharmacol Exp Ther 255 1990 1371 1376
25. Le Bricquir Y, D Larrey, P Blanc, GP Pageaux, Michel H Tianeptine-an instance of drug-induced hepatotoxicity predicted by prospective experimental studies J Hepatol 21 1994 771 773
26. Srivastava IK, H Rottenberg, Vaidya AB Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malaria parasite J Biological Chem 272 1997 3961 3966
27. Bonnet F, M Bonarek, P Morlat Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse-transcriptase inhibitors: a case-control study Clin Infect Dis 36 2003 1324 1328
28. Dieterich DT Long term complications of nucleoside reverse transcriptase inhibitor therapy AIDS Read 13 2003 176 187
29. Falco V, D Rodriguez, E Ribera Severe nucleoside associated lactic acidosis in human immunodeficiency virus infected patients: repor of 12 cases and review of the literature Clin Infect Dis 34 2002 838 846
30. Gerard Y, N Viget, Y Yazdanpanah Hyperlactatemia during anti-retroviral therapy: incidences, clinical data, and treatment Therapie 58 2003 153 158
31. Montaner JS, HC Cote, M Harris Nucleoside-related mitochondrial toxicity among HIV-infected patients receiving antiretroviral therapy: insights from the evaluation of venous lactic acid and peripheral blood mitochondrial DNA Clin Infect Dis 38 suppl 2 2004 S73 S79
32. Delgado J, M Harris, A Tesiorowski, Montaner JS Symptomatic elevations of lactic acid and their response to treatment manipulation in human immunodeficiency virus-infected persons: a case series Clin Infect Dis 33 2001 2072 2074
33. Lonergan JT, RE Barber, Mathews WC Safety and efficacy of switching to alternative nucleoside analogues following symptomatic hyperlactatemia and lactic acidosis AIDS 17 2003 2495 2499